Browse result page of THPdb

The total number entries retrieved from this search are 44

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1005	ThPPIDTh1002	NameCetuximab	Peptide SequenceHeavy chain:QVQLKQSG Full view	Length243	Functional ClassificationIIIc	DiseaseCancer	BrandErbitux	CompanyImClone Systems Inc	Physical AppearanceSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetEpidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1025	ThPPIDTh1004	NameDenileukin diftitox	Peptide SequenceMGADDVVDSSKSFVMENFSS Full view	Length255	Functional ClassificationIIb	DiseaseCancer	BrandOntak	CompanySeragen Inc	Physical AppearanceSterile, white, preservative-free, lyophilized powder.	Route of AdministartionIntravenous(IV) administration	CategoryAntineoplastic Agents	TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma
ID1038	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandEligard	CompanyAtrix Labs/QLT In	Physical AppearanceSuspension	Route of AdministartionSubcutaneous Injection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1039	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandEnantone	CompanyTakeda	Physical AppearanceSolution	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1040	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeuplin	CompanyTakeda	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1041	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeuProMaxx	CompanyBaxter/Teva	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1042	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeupromer	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1043	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLupron	CompanyAbbott/TAP Pharmaceuticals	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1044	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLutrate	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1045	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandMemryte	CompanyCuraxis	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1046	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandProstap 3	CompanyTakeda UK Limited	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1047	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandProstap SR	CompanyTakeda UK Limited	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1048	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandViadur	CompanyBayer AG	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1142	ThPPIDTh1020	NameAsparaginase	Peptide SequenceQMSLQQELRYIEALSAIVET Full view	Length255	Functional ClassificationIc	DiseaseCancer	BrandElspar	CompanyMerck & Co. Inc	Physical AppearanceLyophilized plug or powder	Route of AdministartionIntravenous or Intramuscular. Intravenous method dose has higher risk of allergic reaction, so often a test dose is given first.	CategoryAntineoplastic Agents	TargetL-asparagine
ID1257	ThPPIDTh1036	NameAldesleukin	Peptide SequenceMAPTSSSTKKTQLQLEHLLL Full view	Length134	Functional ClassificationIb	DiseaseCancer/Infectious	BrandProleukin	CompanyChiron Corp	Physical AppearanceSterile, white to off-white, lyophilized cake	Route of AdministartionIntravenous administration	CategoryAntineoplastic Agents, Anti-HIV agents	TargetInterleukin-2 receptor subunit beta,Interleukin-2 receptor subunit alpha,Cytokine receptor common subunit gamma
ID1337	ThPPIDTh1048	NamePegaspargase	Peptide SequenceMEFFKKTALAALVMGFSGAA Full view	Length255	Functional ClassificationIc	DiseaseCancer	BrandOncaspar	CompanyEnzon Inc	Physical AppearanceSolution	Route of AdministartionIntravenous or Intramuscular administration	CategoryAntineoplastic Agents	TargetL-asparagine
ID1341	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandAvonex	CompanyBiogen Inc	Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.	Route of AdministartionIntramuscular Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1342	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaferon	CompanyBayer	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1343	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaseron	CompanyMerck	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1344	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBlastoferon	CompanySidus	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1345	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandExtavia	CompanyNovartis	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1346	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandRebif	CompanyMerck	Physical AppearanceSterile solution in a prefilled syringe or REBIF Rebidose autoinjector	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1385	ThPPIDTh1061	NameTrastuzumab	Peptide SequenceLight chain 1: DIQMT Full view	Length1364	Functional ClassificationIIa	DiseaseCancer	BrandHerceptin	CompanyGenentech	Physical AppearanceSterile, white to pale yellow, preservative-free lyophilized powder	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1548	ThPPIDTh1117	NameIpilimumab	Peptide SequenceHeavy chain: QVQLVES Full view	Length663	Functional ClassificationIIIc	DiseaseCancer	BrandYERVOY	CompanyBristol-Myers Squibb	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	Route of AdministartionN.A.	CategoryAntineoplastic Agents and Monoclonal antibodies	TargetCytotoxic T-lymphocyte protein 4
ID1615	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandEylea	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, clear, and colorless to pale yellow solution.	Route of AdministartionIntravitreal injection	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1616	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandZaltrap	CompanySanofi and Regeneron Pharmaceuticals, Inc.	Physical AppearanceSterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1636	ThPPIDTh1142	NameObinutuzumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseCancer	BrandGazyva	CompanyGenentech	Physical AppearanceSterile, clear, colorless to slightly brown, preservative free liquid concentrate	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetB-lymphocyte antigen CD20
ID1671	ThPPIDTh1159	NameGemtuzumab ozogamicin	Peptide SequenceLight Chain 1: QIVLT Full view	Length459	Functional ClassificationIIb	DiseaseCancer	BrandMylotarg	CompanyWyeth pharmaceuticals inc	Physical AppearanceSterile, white, preservative-free lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic agents and Immunotoxins	TargetMyeloid cell surface antigen CD33, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1708	ThPPIDTh1170	NameBlinatumomab	Peptide SequenceDIQLTQSPASLAVSLGQRAT Full view	Length504	Functional ClassificationIIIc	DiseaseCancer/Genetic	BrandBlincyto	CompanyAMGEN	Physical AppearanceLyophilized Powder for intravenous administration	Route of AdministartionIntravenous	CategoryAntineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	TargetB-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
ID1724	ThPPIDTh1174	NameDaratumumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIc	DiseaseCancer	BrandDarzalex	CompanyJanssen Biotech, Inc.	Physical AppearanceSolution, concentrate	Route of AdministartionIntravenous	CategoryAntineoplastic Agents	TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
ID1797	ThPPIDTh1191	NameVedolizumab	Peptide SequenceHeavy Chain Sequence Full view	Length716	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandEntyvio	CompanyTakeda Pharmaceuticals America, Inc.	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryImmunosupressive agent, Antineoplastic agent	TargetIntegrin alpha-4, Integrin beta-7
ID1798	ThPPIDTh1192	NameUstekinumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIb	DiseaseInfectious Disease	BrandStelara	CompanyJanssen Biotech, Inc.	Physical AppearanceSolution fro Injection	Route of AdministartionSubcutaneous	CategoryDeramtologic agent, Immunosuppressive agent, antineoplastic agent	TargetInterleukin-12 subunit beta
ID1802	ThPPIDTh1196	NameSiltuximab	Peptide SequenceHeavy Chain Sequence Full view	Length708	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandSylvant	CompanyJanssen Inc	Physical AppearanceLyophilized Powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic and Immunomodulating Agents, Immunosuppressive Agents	TargetInterleukin-6
ID1805	ThPPIDTh1199	NameRamucirumab	Peptide Sequenceramucirumab|Homo sap Full view	Length909	Functional ClassificationIIIc	DiseaseCancer	BrandCyramza	CompanyEli Lilly and Company	Physical AppearanceSolution	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetVascular endothelial growth factor receptor 2
ID1811	ThPPIDTh1202	NamePembrolizumab	Peptide SequenceHeavy Chain Sequence Full view	Length711	Functional ClassificationIIIc	DiseaseCancer	BrandKeytruda	CompanyMerck Sharp & Dohme Corp.	Physical AppearanceLyophilized Powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic and Immunomodulating Agents	TargetProgrammed cell death protein 1
ID1813	ThPPIDTh1204	NameOfatumumab	Peptide SequenceOfatumumab Heavy Cha Full view	Length483	Functional ClassificationIIIc	DiseaseCancer	BrandArzerra	CompanyGlaxo Smith Kline Llc	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	Target
ID1815	ThPPIDTh1206	NameNivolumab	Peptide SequenceHeavy Chain Sequence Full view	Length710	Functional ClassificationIIIc	DiseaseCancer	BrandOpdivo	CompanyE.R. Squibb & Sons, L.L.C.	Physical AppearanceLiquid	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetProgrammed cell death protein 1
ID1819	ThPPIDTh1210	NameMepolizumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIb	DiseaseRespiratory Disorder	BrandNucala	CompanyGlaxosmithkline Inc	Physical AppearanceLyophilized Powder	Route of AdministartionSubcutaneous	CategoryAntineoplastic and Immunomodulating Agents, Immunosuppressive Agents, Interleukin Inhibitors	TargetInterleukin-5
ID1830	ThPPIDTh1220	NameBrodalumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandSiliq	CompanyNA	Physical Appearancesterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution	Route of AdministartionSubcutaneous	CategoryAntineoplastic and Immunomodulating Agents	Target Interleukin 17 receptor A
ID1832	ThPPIDTh1222	NameCanakinumab	Peptide SequenceH-GAMMA-1 Chain: QVQ Full view	Length842	Functional ClassificationIIa	DiseaseImmunological Disorders	BrandIlaris	CompanyNovartis	Physical AppearanceLyphilized powder	Route of AdministartionSubcutaneous	CategoryAntineoplastic and Immunomodulating Agents	TargetInterleukin-1 beta
ID1837	ThPPIDTh1226	NameDinutuximab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIc	DiseaseCancer	Brandunituxin	CompanyNA	Physical Appearancesterile, preservative-free, clear/colorless to slightly opalescent solution	Route of AdministartionIntravenous	CategoryAntibody, Immunosuppresive agent, Antineoplastic agent	TargetGanglioside GD2 (small molecule)
ID1844	ThPPIDTh1232	NameLenograstim	Peptide SequenceNA Full view	Length0	Functional ClassificationIb	DiseaseImmunological Disorders	BrandGranocyte	CompanyNA	Physical AppearanceSolid	Route of AdministartionSubcutaneous or Intravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetGranulocyte colony-stimulating factor receptor
ID1848	ThPPIDTh1236	NameSipuleucel-T	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIc	DiseaseCancer	BrandProvenge	CompanyNA	Physical AppearanceSolution	Route of AdministartionIntravenous	CategoryAntineoplastic and Immunomodulating Agents	TargetProstatic acid phosphatase